4.6 Article

Multi-predictor modeling for predicting early Parkinson's disease and non-motor symptoms progression

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Update on CSF Biomarkers in Parkinson's Disease

Eun Hae Kwon et al.

Summary: This paper emphasizes the importance of reliable objective markers for identifying individuals at risk of Parkinson's disease. Advances in biomarker discovery, particularly in the cerebrospinal fluid (CSF), have provided promising preliminary results. Potential biomarkers include alpha-synuclein species, markers of amyloid and tau pathology, neurofilament light chain, lysosomal enzymes, and markers of neuroinflammation. Metabolomics approaches have also offered insights into novel biological pathways. Genetic forms of PD can help identify subgroups suitable for targeted treatments. Further validation studies are needed to determine the most valuable CSF biomarkers or combinations for clinical and research purposes.

BIOMOLECULES (2022)

Review Clinical Neurology

Towards early disease modification of Parkinson's disease: a review of lessons learned in the Alzheimer field

Marthe Smedinga et al.

Summary: Research on Parkinson's disease (PD) is increasingly focusing on early disease modification and prevention, similar to strategies seen in Alzheimer's disease research. Challenges faced in Alzheimer's prevention trials, including insufficiently robust trial results and trial design flaws, also apply to PD research and need to be addressed for optimal trial design.

JOURNAL OF NEUROLOGY (2021)

Article Geriatrics & Gerontology

Motor Progression in Early-Stage Parkinson's Disease: A Clinical Prediction Model and the Role of Cerebrospinal Fluid Biomarkers

Ling-Yan Ma et al.

Summary: By utilizing machine learning and routinely gathered assessments, this study developed multiple dynamic models to predict the next year's motor progression in patients with Parkinson's disease. These models enable clinicians to tailor medical management for patients and identify at-risk individuals for disease-modifying therapies in future clinical trials.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Article Neurosciences

Predictors of clinically significant quality of life impairment in Parkinson's disease

Santos D. Garcia et al.

Summary: Age, gender, mood, and non-motor impairment were associated with clinically significant health-related quality of life (HRQoL) impairment after the 2-year follow-up in Parkinson's disease patients.

NPJ PARKINSONS DISEASE (2021)

Article Clinical Neurology

Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of Change

Xuehan Ren et al.

Summary: Predicting Parkinson's disease progression using longitudinal clinical measures enhances prognostic model performance. The proposed model allows clinicians to classify patients into different risk groups for better prognosis discussion.

MOVEMENT DISORDERS (2021)

Article Clinical Neurology

CSF or serum neurofilament light added to α-Synuclein panel discriminates Parkinson's from controls

Linda P. Oosterveld et al.

MOVEMENT DISORDERS (2020)

Article Clinical Neurology

REM sleep behavior disorder predicts functional dependency in early Parkinson's disease

Ryul Kim et al.

PARKINSONISM & RELATED DISORDERS (2019)

Article Clinical Neurology

The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort

Kenneth Marek et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)

Review Neurosciences

Non-motor features of Parkinson disease

Anthony H. V. Schapira et al.

NATURE REVIEWS NEUROSCIENCE (2017)

Review Neurosciences

Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease

Michelle E. Fullard et al.

NEUROSCIENCE BULLETIN (2017)

Review Clinical Neurology

α-Synuclein and Parkinsonism: Updates and Future Perspectives

Kaie Rosborough et al.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2017)

Article Clinical Neurology

Baseline genetic associations in the Parkinson's Progression Markers Initiative (PPMI)

Mike A. Nalls et al.

MOVEMENT DISORDERS (2016)

Article Clinical Neurology

Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression

Nour K. Majbour et al.

MOVEMENT DISORDERS (2016)

Article Clinical Neurology

Nonmotor features of Parkinson's disease subtypes

Connie Marras et al.

MOVEMENT DISORDERS (2016)

Review Clinical Neurology

MDS clinical diagnostic criteria for Parkinson's disease

Ronald B. Postuma et al.

MOVEMENT DISORDERS (2015)

Article Clinical Neurology

Health-related quality of life in early Parkinson's disease: The impact of nonmotor symptoms

Gordon W. Duncan et al.

MOVEMENT DISORDERS (2014)

Review Clinical Neurology

Cerebrospinal fluid biomarkers in Parkinson disease

Lucilla Parnetti et al.

NATURE REVIEWS NEUROLOGY (2013)

Review Clinical Neurology

Identifying prodromal Parkinson's disease: Pre-Motor disorders in Parkinson's disease

Ronald B. Postuma et al.

MOVEMENT DISORDERS (2012)

Review Public, Environmental & Occupational Health

Epidemiology and etiology of Parkinson's disease: a review of the evidence

Karin Wirdefeldt et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2011)

Article Clinical Neurology

Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson's disease

Juan Carlos Gomez-Esteban et al.

JOURNAL OF NEUROLOGY (2011)

Review Neurosciences

The Parkinson Progression Marker Initiative (PPMI)

Kenneth Marek et al.

PROGRESS IN NEUROBIOLOGY (2011)

Review Clinical Neurology

The scientific and clinical basis for the treatment of Parkinson disease (2009)

C. Warren Olanow et al.

NEUROLOGY (2009)

Article Genetics & Heredity

Genetic Association Between α-Synuclein and Idiopathic Parkinson's Disease

Denise M. Kay et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2008)

Article Clinical Neurology

Depressive symptoms in Parkinson's disease

M. R. Lemke

EUROPEAN JOURNAL OF NEUROLOGY (2008)

Article Clinical Neurology

Dementia and survival in Parkinson disease - A 12-year population study

T. C. Buter et al.

NEUROLOGY (2008)

Review Clinical Neurology

A systematic review of prevalence studies of depression in Parkinson's disease

Jennifer S. A. M. Reijnders et al.

MOVEMENT DISORDERS (2008)

Review Clinical Neurology

A systematic review of prevalence studies of dementia in Parkinson's disease

D Aarsland et al.

MOVEMENT DISORDERS (2005)

Article Clinical Neurology

Idiopathic hyposmia as a preclinical sign of Parkinson's disease

MM Ponsen et al.

ANNALS OF NEUROLOGY (2004)

Article Clinical Neurology

What contributes to quality of life in patients with Parkinson's disease?

A Schrag et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)